These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7111380)

  • 1. Effects on gastric prostaglandin synthesis produced by fenbufen, a new nonsteroidal anti-inflammatory agent with low gastrointestinal toxicity.
    Birnbaum JE; Tolman EL; Sloboda AE; Sparano BM; McClintock DK
    Pharmacology; 1982; 25 Suppl 1():27-38. PubMed ID: 7111380
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacological properties of fenbufen. A review.
    Sloboda AE; Tolman EL; Osterberg AC; Panagides J
    Arzneimittelforschung; 1980; 30(4A):716-21. PubMed ID: 7002162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic properties of fenbufen.
    Kerwar SS
    Am J Med; 1983 Oct; 75(4B):62-9. PubMed ID: 6356910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function.
    Kohler C; Tolman E; Wooding W; Ellenbogen L
    Arzneimittelforschung; 1980; 30(4A):702-7. PubMed ID: 6254545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of fenbufen.
    Kerwar SS; Sloboda AE
    Pharmacology; 1982; 25 Suppl 1():12-20. PubMed ID: 7111379
    [No Abstract]   [Full Text] [Related]  

  • 6. Fenbufen and biphenylacetic acid inhibit platelet function and the arachidonate prostaglandin system.
    Kohler C; Tolman E; Wooding W; Ellenbogen L
    Thromb Res; 1980 Oct; 20(1):123-35. PubMed ID: 6782695
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study of interactions between 4-biphenylacetic acid and sulfamethizole, and between fenbufen and sulfamethizole in rats.
    Chiba K; Kikuchi S; Higuchi N; Miyazaki S; Takada M
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4389-93. PubMed ID: 3829171
    [No Abstract]   [Full Text] [Related]  

  • 8. Side effect and safety data for fenbufen.
    Crossley RJ
    Am J Med; 1983 Oct; 75(4B):84-90. PubMed ID: 6227235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the incidence of peptic ulceration for fenbufen, indomethacin and aspirin treated patients compared with the general population.
    Cohen PM
    J Int Med Res; 1986; 14(2):67-71. PubMed ID: 3516753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prostaglandin activity and synthesis by fenbufen (a new nonsteroidal antiinflammatory agent) and one of its metabolites.
    Tolman EL; Birnbaum JE; Chiccarelli FS; Panagides J; Sloboda AE
    Adv Prostaglandin Thromboxane Res; 1976; 1():133-8. PubMed ID: 826139
    [No Abstract]   [Full Text] [Related]  

  • 11. Fenbufen in osteoarthritis of the hip.
    Tait B
    Pharmacology; 1982; 25 Suppl 1():73-8. PubMed ID: 7111386
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of selected investigational nonsteroidal antiinflammatory drugs of the 1980s.
    Marsh CC; Schuna AA; Sundstrom WR
    Pharmacotherapy; 1986; 6(1):10-25. PubMed ID: 2937024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Orienting animal experiment studies on the effect of fenbufen on healthy and arthrosis-induced articular cartilage tissue in vivo].
    Kalbhen DA
    Z Rheumatol; 1985; 44(4):167-71. PubMed ID: 4050149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fenbufen and indomethacin: a comparative study in rheumatoid arthritis.
    Burton WD; Hazleman BL
    Clin Ther; 1983; 5(3):260-7. PubMed ID: 6342784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenbufen.
    Arzneimittelforschung; 1980; 30(4A):693-746. PubMed ID: 7192121
    [No Abstract]   [Full Text] [Related]  

  • 16. Rare adverse reactions to nonsteroidal antiinflammatory drugs (3).
    O'Brien WM; Bagby GF
    J Rheumatol; 1985 Jun; 12(3):562-7. PubMed ID: 3900394
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-steroidal anti-inflammatory agents. A practical review].
    Kraus A; Ibáñez de Kasep G
    Rev Invest Clin; 1985; 37(2):153-64. PubMed ID: 4035123
    [No Abstract]   [Full Text] [Related]  

  • 18. [Skin lesions related to a new anti-inflammatory agent: fenbufen. Apropos of 3 clinical cases].
    Nicolas C; Chouvet B; Cambazard F; Bernollin C; Thivolet J
    Ann Dermatol Venereol; 1983; 110(5):419-23. PubMed ID: 6226230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term, double-blind, randomized parallel group studies comparing fenbufen with indometacin in patients with osteoarthritis.
    Salzman RT; Reid RT
    Pharmacology; 1982; 25 Suppl 1():54-62. PubMed ID: 7111384
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological study of 6,11-dihydro-11-oxodibenz[b,e]oxepin-3-acetic acid (oxepinac): a new antiinflammatory drug.
    Tsukada W; Tsubokawa M; Masukawa T; Kojima H; Kasahara A
    Arzneimittelforschung; 1978; 28(3):428-38. PubMed ID: 580752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.